POLICY IMPACT COMMUNICATIONS, INC.

Lobbying for CHROMADEX · Niagen bioscience focusing on the potential of NAD+.

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · posted Aug 15, 2025

Lobbying activity 1

Health Issues

Protecting DSHEA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem